ACCRUED LIABILITIES

3 Months Ended

Mar. 31, 2024

Payables and Accruals [Abstract]

ACCRUED LIABILITIES

NOTE 6. ACCRUED LIABILITIES

As of March 31, 2024 and December 31, 2023, the accrued liabilities of the Company consisted of the following:

	March 31, 2024		December 31, 2023
Product development	$	70,989	$	139,981
Accrued salaries, wages, and bonuses		112,708		8,889
Professional fees		172,235		584,810
Accrued restructuring costs (see Note 8)		113,532		301,645
Accrued income taxes		—		22,318
Patent costs		18,000		18,000
Total accrued expenses	$	487,464	$	1,075,643

ENVERIC BIOSCIENCES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS